Operations, technology, quality, and digital transformation across biotechnology organizations.

Chief Technology Officer

Cell Culture Company (formerly Biovest International) | Shoreview, MN

Lead enterprise technology strategy and digital transformation for a biologics CDMO. Focused on building practical tools and systems that reduce manual work, improve decision-making, and connect quality, operations, and commercial execution.

• Built Python-based ERP automation for purchase order processing, cutting processing time by roughly 50%.
• Developed an AI-powered vendor pricing agent that compares negotiated pricing across suppliers and recommends purchasing adjustments based on actual patterns.
• Driving the roadmap and system integration design for the C3 Platform, an enterprise operations platform spanning multiple business functions.
• Automated board-level reporting by building tools that pull from disparate data sources, eliminating manual compilation.
• Restructured Google Ads from a misallocated configuration to a focused B2B search strategy targeting niche life-science buyers, significantly improving conversion volume, cost per conversion, and qualified lead quality year over year.
• Implemented offline conversion tracking and a Qualified Lead conversion action to enable meaningful ROI measurement for the first time.
• Deployed Claude Team (Anthropic AI) company-wide and managed adoption across the organization.

Chief Executive Officer

Cell Culture Company (formerly Biovest International) | Coon Rapids / Shoreview, MN

Led corporate strategy, P&L, and full operational and commercial accountability for a biologics CDMO. Redirected strategy, rebuilt quality infrastructure, led the company through COVID-19 disruption and post-pandemic normalization, launched a third business division, and completed a full GMP facility relocation before transitioning to CTO in January 2026.

• Grew revenue 61% and expanded gross margins by 27 percentage points in the first two years by refocusing strategy on the company's core Bioservices and Instruments divisions.
• Sustained profitability in five of six years as CEO; net income improved roughly 10x from the pre-CEO baseline at peak.
• Led a full GMP facility relocation from a 33,000 sq ft building in Coon Rapids to a 21,000 sq ft purpose-built space in Shoreview, on time and under a $1.3M budget, without disrupting customer operations or regulatory compliance.
• Launched Cell Line Development as a third business division, expanding commercial scope and service portfolio.
• Partnered with the Board of Directors and ownership on strategic priorities, resource allocation, and long-term planning.
• Reshaped organizational structure and leadership accountabilities to improve cross-functional execution and decision-making.

Operations, Quality, and Scientific Leadership

Cell Culture Company / Biovest International | Pharmasan Labs | University of Toledo Health Science Campus

Built the cross-functional foundation that later informed executive leadership, including CDMO operations, ISO 9001 certification, cGMP quality systems, regulated laboratory operations, clinical laboratory work, immunological assay development, and translational immunology research.